Cargando…
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication
Previous work has shown that the Tat protein of Human Immunodeficiency Virus (HIV)-1 is released by acutely infected cells in a biologically active form and enters dendritic cells upon the binding of its arginine-glycine-aspartic acid (RGD) domain to the α5β1, αvβ3, and αvβ5 integrins. The up-regula...
Autores principales: | Cafaro, Aurelio, Barillari, Giovanni, Moretti, Sonia, Palladino, Clelia, Tripiciano, Antonella, Falchi, Mario, Picconi, Orietta, Pavone Cossut, Maria Rosaria, Campagna, Massimo, Arancio, Angela, Sgadari, Cecilia, Andreini, Claudia, Banci, Lucia, Monini, Paolo, Ensoli, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796023/ https://www.ncbi.nlm.nih.gov/pubmed/33396807 http://dx.doi.org/10.3390/ijms22010317 |
Ejemplares similares
-
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease
por: Cafaro, Aurelio, et al.
Publicado: (2019) -
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
por: Ensoli, Barbara, et al.
Publicado: (2021) -
Anti-Tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART.
por: Tripiciano, Antonella, et al.
Publicado: (2021) -
Kaposi’s Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies
por: Brocca-Cofano, Egidio, et al.
Publicado: (2022) -
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
por: Ensoli, Barbara, et al.
Publicado: (2016)